Additional file 1 of SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023

Additional file 1. Table 1 Antibodies against the SARS-CoV-2 spike (S) and nucleocapsid (N) proteins at 12 (T1) and 24 months (T2) following initial PCR testing for our fully and booster-immunized participants.

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29232060
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023

Figshare
SARS-CoV-2 and COVID-19 Research
article

Additional file 1 of SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023

article en

Abstract

Additional file 1. Table 1 Antibodies against the SARS-CoV-2 spike (S) and nucleocapsid (N) proteins at 12 (T1) and 24 months (T2) following initial PCR testing for our fully and booster-immunized participants.

Figshare
Norwegian Institute of Public Health (NO), University of Oslo (NO), University of Agder (NO), Norwegian University of Science and Technology (NO), London School of Hygiene & Tropical Medicine (GB), Sørlandet Hospital Arendal (NO), St Olav's University Hospital (NO), Telemark Hospital (NO), Sørlandet Sykehus (NO)
Openalex Percentile: Top 46%
SARS-CoV-2 and COVID-19 Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.